Augmented GLP-1 actions include anti-inflammatory, potent glycemic and body weight reduction effects (4); therefore, GLP-1 RA is highly recommended for T2D patients with cardiovascular risk factors (5). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.